BREAKTHROUGH T1D Trademark
BREAKTHROUGH T1D is a USPTO trademark filed by BREAKTHROUGH T1D. Status: Pending.
Trademark Facts
| Mark | BREAKTHROUGH T1D |
|---|---|
| Serial Number | 98527916 |
| Status | Pending |
| Filing Date | 2024-04-30 |
| Mark Type | Combined |
| Nice Classes | 035 (Advertising & Business), 036 (Financial Services), 042 (Software & IT), 044 (Medical Services) |
| Owner | BREAKTHROUGH T1D |
| Attorney of Record | Emily R. Billig |
| Prosecution Events | 19 |
| Latest Event | SUPC on 2026-04-21 |
Goods & Services
Charitable fundraising; online charitable fundraising; charitable fundraising services by means of organizing and conducting special events; charitable fundraising services by means of running and walking events; charitable fundraising services for promoting research and education relating to type 1 diabetes; charitable foundation services, namely, providing fundraising activities and investment management services to support type 1 diabetes research; Association services, namely, promoting the public interest and awareness of curing, treating, and preventing type 1 diabetes; promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy; Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes; Providing an online searchable database featuring medical information regarding type 1 diabetes; "T1D"; Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Providing an online searchable database in the field of scientific research on type 1 diabetes, for scientific research purposes